These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 12607585

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines.
    Caca K, Feisthammel J, Klee K, Tannapfel A, Witzigmann H, Wittekind C, Mössner J, Berr F.
    Int J Cancer; 2002 Feb 01; 97(4):481-8. PubMed ID: 11802210
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mutations of the DPC4/Smad4 gene in biliary tract carcinoma.
    Hahn SA, Bartsch D, Schroers A, Galehdari H, Becker M, Ramaswamy A, Schwarte-Waldhoff I, Maschek H, Schmiegel W.
    Cancer Res; 1998 Mar 15; 58(6):1124-6. PubMed ID: 9515793
    [Abstract] [Full Text] [Related]

  • 9. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
    Kasuga A, Semba T, Sato R, Nobusue H, Sugihara E, Takaishi H, Kanai T, Saya H, Arima Y.
    Cancer Sci; 2021 May 15; 112(5):1822-1838. PubMed ID: 33068050
    [Abstract] [Full Text] [Related]

  • 10. Beta-catenin mutations in biliary tract cancers: a population-based study in China.
    Rashid A, Gao YT, Bhakta S, Shen MC, Wang BS, Deng J, Fraumeni JF, Hsing AW.
    Cancer Res; 2001 Apr 15; 61(8):3406-9. PubMed ID: 11309300
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver.
    Tannapfel A, Benicke M, Katalinic A, Uhlmann D, Köckerling F, Hauss J, Wittekind C.
    Gut; 2000 Nov 15; 47(5):721-7. PubMed ID: 11034592
    [Abstract] [Full Text] [Related]

  • 16. Molecular Characterization of Biliary Tract Cancer Predicts Chemotherapy and Programmed Death 1/Programmed Death-Ligand 1 Blockade Responses.
    Yoon JG, Kim MH, Jang M, Kim H, Hwang HK, Kang CM, Lee WJ, Kang B, Lee CK, Lee MG, Chung HC, Choi HJ, Park YN.
    Hepatology; 2021 Oct 15; 74(4):1914-1931. PubMed ID: 33884649
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand.
    Kiba T, Tsuda H, Pairojkul C, Inoue S, Sugimura T, Hirohashi S.
    Mol Carcinog; 1993 Oct 15; 8(4):312-8. PubMed ID: 8280380
    [Abstract] [Full Text] [Related]

  • 20. Oncogenes in tumors of gallbladder and biliary tract.
    Enjoji M, Nakamuta M, Nawata H.
    Fukuoka Igaku Zasshi; 2004 Feb 15; 95(2):31-5. PubMed ID: 15101197
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.